DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

戻る Agenda

DIA Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Session Chair(s)

Representative Invited

DIA, United States

Attend to learn more or meet fellow members, hear about what’s happening in the working group, and join in the latest discussions on the latest hot topics.

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Session Chair(s)

Representative Invited

最新情報や機会を逃さないで